Clinical Trials Browser

Phase 1/2 × Recruiting × Cancer Vaccines × Clear all

NCT05101356 2024-05-21

A Cancer Vaccine (Labvax 3(22)-23) and GM-CSF Alone or in Combination With Pembrolizumab for the Treatment of Advanced Stage Adenocarcinoma

Phase 1/2 Recruiting

Adenocarcinoma, Neoplasm Metastasis